Skip to content

Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men

Informed Decision-Making Regarding PSA Screening

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00761124
Acronym
PSA
Enrollment
1006
Registered
2008-09-29
Start date
2003-04-01
Completion date
2022-04-01
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

PSA screening, Prostate cancer and Latino men

Brief summary

The purpose of this intervention trial is aiming to increase inform decision- making in Latino men regarding prostate cancer screening. The investigators propose to find out how much Latino men know about the benefits and risks of prostate cancer screening and what factors influence how they decide whether or not to have screening. The investigators are also interested in learning how providing education information, both verbally and in print, about the risks and benefits of prostate cancer screening affects men's interest and knowledge. The intervention is an interactive multi-media presentation made up of a small group of 8-10 Latino men gathered to discuss about prostate cancer, screening methods, treatment, and the controversy within the medical community regarding PSA screening. A facilitator guides the 1-hour discussion and encourages participant interaction. The effect of this intervention was tested on 1000 Latino men within Los Angeles county. Participants were recruited from 38 community venues (churches, community center, etc.). All participants were interviewed before being randomized to receive written (control group) or oral (intervention) prostate cancer education material. All of the participants will be followed up at 6-months via a telephone interview. The investigators hypothesize that the intervention group will have an increase knowledge of prostate cancer, will have increase communication with family, friends, and medical provider, and will have an increase rate of PSA screening compared to the control group.

Interventions

BEHAVIORALIntervention Session

A one-hour discussion group composed of 8-10 Latino men. The session includes an interactive, multimedia presentation led by a facilitator to guide participant interaction.

General prostate cancer pamphlet

Sponsors

Jonsson Comprehensive Cancer Center
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
50 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Latino men * 50 to 70 years old * Not ever having prostate biopsy * Not ever having prostate cancer * Not having had a PSA test within the past 12 months * Not having BPH (prostate inflammation) * Not currently experiencing prostate problems such as pain or burning sensation during urination, blood in urine, and/or desire to urinate frequently

Exclusion criteria

* Not Latino * Younger than 50 or older than 70 years old * Currently experiencing prostate problems such as pain or burning sensations while urinating, blood in urine, and/or desire to urinate frequently * Living outside of Los Angeles county * Having had a prostate biopsy * Having had prostate cancer previously * Having had a prostatectomy

Design outcomes

Primary

MeasureTime frame
Inform Decision-Making6 months post-baseline interview

Secondary

MeasureTime frame
Prostate cancer knowledge, Receipt of PSA, and Communication with family, friends, and medical providers6 months post-baseline interview

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRoshan Bastani, PhD

University of California, Los Angeles

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026